Journal of Intellectual Property Rights

Open Access Open Access  Restricted Access Subscription Access

International Legal Obligation of the State with reference to Intellectual Property Rights (Patents) vis-a- vis Right to Health:The Indian Case Study


Affiliations
1 Gujarat National Law University, Attalika Avenue, Knowledge Corridor, PDPU Road, Koba, Gandhinagar, Gujarat-382 426, India
 

The problem exists is between the constitutional obligation of the state (India) under fundamental rights, ie. Human rights to health, on one hand and international legal and economical obligations under the trade agreements, ie. WTO, TRIPS etc., on other hand. Intellectual property rights of pharmaceuticals are governed by patent law. India being a signatory of the GATT1 is governed by TRIPS apart from having its own national Intellectual Property Law. Members are held responsible under the human rights treaties to protect, promote and fulfilled the basic and minimum requirements of an individual in the state. While on the other side, the trade agreements and treaties does not provide sufficient space to protect those human rights. If the state has signed the trade related agreements they are required to protect the interest of the seller and it would be challenging for the signatory state to maintain balance between the interest of a seller and protection of right health.

This article explores the existing constitutional, legal and international provisions pertaining to right to health and patent laws in India. Theis article analyses judicial decisions passed by the Supreme Court of India on right to health, on TRIPS provisions and its implementations. The article has underlined existing situation and its interplay between human rights and pharma-patents. The article endorse on right to health as human rights and constitutional rights vis a vis patent’s right under the trade agreements in India. The article explored the practice of pharmaceutical industry and its conflict with idea of right to health by analysis of landmark judgment Novartis Ag. v Union of India & Others, decided by the Supreme Court of India on 1 April 2013.The article further deliberates on access to patented medicines under the TRIPS.


Keywords

TRIPS, WHO, WIPO, WTO, Doha Declaration, PIL, Sustainable Development Goals.
User
Notifications
Font Size

  • https://www.wto.org/ english/ thewto_e/countries_e/india_e.htm, (accessed on 20 November 2017).

  • World Health Statistics, 2017: Monitoring health for the SDGs, Sustainable Development Goals, Geneva: World Health Organization; 2017.

  • http://www.un.org/ millenniumgoals/bkgd.shtml, (accessed on 20 August 2017).

  • Medium-term Strategic Plan 2008–2013. Geneva: World Health Organization: 96 http://apps.who.int/gb/ebwha/pdf_ files/MTSP-08-13-PPB-10-11/mtsp-3en.pdf. (accessed on 19 August 2017).

  • Jha P, Current Government Policies Towards Health, Education and Poverty Alleviation in India: An Evaluation, http://www.macroscan.org/ fet/sep03/pdf/Praveen_Jha_Paper.pdf (accessed on 19 August 2017).

  • Wei Xiaolu (Erin), Drugs and Intellectual Property Rights, http://web.mit.edu/ lawclub/www/Drugs%20and%20Intellectual %20Property%20Right1.pdf, (accessed on 21 November 2017).

  • Harvey E Bale Jr, The conflict between parallel trade and product access and innovation: The case of pharmaceuticals, Journal of International Economic Law, I (1998) 637.

  • https://www.wto.org/ english/tratop_e/trips_e/trilatweb_e/ch1b_ trilat_web_13_e.htm, (accessed on 20 August 2017).

  • http://www.who.int/ healthacademy/collaboration/en/ (accessed on 20 August 2017).

  • www.wipo.int/ip-development/ en/agenda/recommendations.html. (accessed on 20 August 2017).

  • WHA, Resolution: WHA61.21: Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property, Para 4(5), https://www.wto.org/ english/tratop_ e/trips_e/trilatweb_e/ch1b_trilat_web_13_e.htm#_edn13, (accessed on 20 August 2017).

  • Hoen E F M’t, TRIPS, pharmaceutical patents and access to essential medicines: Seattle, Doha and beyond, T’Hoen.qxd 25/06/2003, p. 39, http://www.who.int/ intellectualproperty/ topics/ip/tHoen.pdf (accessed on 19 August 2017).

  • United Nations Economic and Social Council, General Comment No. 14: The Right to the Highest Attainable Standard of Health. United Nations Document E/C.12/2000/4 (accessed on 11 August 2000): Para. 43(d); Hogerzeil H &Mirza Z, The World Medicines Situation, 2011: Access to essential medicines as part of the right to health, Geneva: World Health Organization; 2011.

  • http://www.doctorswithoutborders.org/ news-stories/briefingdocument/ qa-patents-india-and-novartis-case (accessed on 21 August 2017).

  • MSF: Access to Essential Medicines Campaign and the Drugs for Neglected Diseases Working Group. Fatal Imbalance: The Crisis in Research and Development for Drugs for Neglected Diseases, September 2001, 10-18, www.msf.org/ source/access/2001/fatal/fatal.pdf. (accessed on 21 August 2017).

  • Scherer M F &Watal J, Post TRIPS options for access to patented medicines in developing countries, WHO, 2001, www.cmhealth.org/docs/wg4_paper1.pdf (accessed on 19 August 2017) (reports on three independent studies that found a mean price increase of well over 200% with the introduction of product patents).

  • World Health Organization: Globalization, TRIPS and Access to Pharmaceuticals, March 2001, www.who.int/ medicines/ library/edm_general/6pagers /PPM03% 20ENG.pdf (accessed on 19 August 2017).

  • WHO- Regional Office for South-East Asia, ‘Intellectual Property Rights and Access to Medicines: A South-East Asia perspective on global issues’, World Health Organization 2008, http://www.searo.who.int/entity/intellectual_property/ trh.pdf (accessed on 21 August 2017).

  • http://www.who.int/ medicines/areas/policy/wto_trips/en/ (accessed on 21 August 2017).

  • http://www.bios.net/daisy/patentlens/2333.html (accessed on 21 November 2017).

  • Article 12.1 of the International Covenant on Economic, Social and Cultural Rights.

  • GostinLawerence O, Public health, ethics and human rights: A tribute to the late Jonathan Mann, Journal of Law, Medicine and Ethics, 29 (Summer 2001) 121-129.

  • http://www.who.int/ about/mission/en/.

  • The Right to Health, Fact Sheet No. 31, United Nations High Commissioner for Human Rights, Geneva, Switzerland.

  • Article 25 of Universal Declaration of Human Rights, 1948.

  • Examples of UN Human Rights Treaties: International Covenant on Economic, Social and Cultural Rights (ICESCR), 1966; Convention on the Elimination of All Forms of Discrimination Against Women (CEDAW), 1979; Convention on the Rights of the Child (CRC), 1989.

  • Examples of regional human rights treaties: European Social Charter, 1961; African Charter on Human and Peoples’ Rights, 1981; Additional Protocol to the American Convention on Human Rights in the Area of Economic, Social and Cultural Rights (the Protocol of San Salvador), 1988.

  • Articles 11(1)(f), 11(2), 12 and 14(2)(b) in the Convention on the Elimination of all forms of Discrimination Against Women (CEDAW); Articles 3(3), 23(3), 23(4) and 24 in Convention on the Rights of the Child (CRC); Article 5(e)(iv) in International Convention on the Elimination of all forms of Racial Discrimination (ICERD).

  • Articles 11 and 13 of the European Social Charter; Article 35 of the Charter of fundamental rights of the European Union; Article XI of the American Declaration on the rights and duties of man; Article 16 of the African Charter on Human and People’s rights; and Article 14 of the African Charter on the Rights and welfare of the Child.

  • Justice V R Krishna Iyer, Human health and patent law, Frontline,17(21) (October 2000) 14–27.

  • Constitution of India, as of 2006 (source: Ministry of Law and Justice, http://indiacode.nic. in/coiweb/welcome.html), http://www.who.int/hhr/news/SEAHHR_RtH_constitutions.pdf, (accessed on 21 August 2017).

  • Article 38, State to secure a social order for the promotion of welfare of the people.—(1) The State shall strive to promote the welfare of the people by securing and protecting as effectively as it may a social order in which justice, social, economic and political, shall inform all the institutions of the national life. (2) The State shall, in particular, strive to minimise the inequalities in income, and endeavour to eliminate inequalities in status, facilities and opportunities, not only amongst individuals but also amongst groups of people residing in different areas or engaged in different vocations.

  • Article 39 (e) that the health and strength of workers, men and women, and the tender age of children are not abused and that citizens are not forced by economic necessity to enter avocations unsuited to their age or strength;

  • Provision for just and humane conditions of work and maternity relief.—The State shall make provision for securing just and humane conditions of work and for maternity relief.

  • Duty of the State to raise the level of nutrition and the standard of living and to improve public health.—The State shall regard the raising of the level of nutrition and the standard of living of its people and the improvement of public health as among its primary duties and, in particular, the State shall endeavour to bring about prohibition of the consumption except for medicinal purposes of intoxicating drinks and of drugs which are injurious to health.

  • Article 48A, Protection and improvement of environment and safeguarding of forests and wild life.—The State shall endeavour to protect and improve the environment and to safeguard the forests and wild life of the country.

  • Khandekar I, Tirpude B H &, Murkey P N, Review Research Paper Right to Health Care, J Indian Acad Forensic Med, 34 (2) April-June (2012).

  • BandhuaMuktiMorcha v Union of India, AIR 1984 SC 802.

  • Vincent Panikulangara v Union of India, AIR 1987 SC 990: 995. p. 995.

  • MahendraPratap Singh v State of Orissa, AIR 1997 Ori 37.

  • Sahara HousevUnion of India, [W.P, (C) No. 535 of 1998].

  • Sankalp Rehabilitation TrustvUnion of India, [W.P. (C) No.512 of 1999].

  • http://www.doctorswithoutborders.org/ news-stories/briefingdocument/ qa-patents-india-and-novartis-case, (accessed on 21 August 2017).

  • GeetaAnand, https://blogs.wsj.com/ indiarealtime/ 2015/03/19/inside-india-indias-fight-against-big-pharmapatentsis-a-just-war/ (accessed on 19 August 2017).

  • Chandru A &Gokhale G, Novartis Indian Supreme Court Judgment: What is Efficacy for Pharmaceutical Invention?, Nishit Desai Associates, https://www.lexology.com/library/ detail.aspx?g=ec8dde78-0fa0-49d8-92c1-10ca15eecc45 (accessed on 19 August 2017).

  • Mattina J L, Pharma& Healthcare, 2013,https://www.forbes.com/sites/johnlamattina/2013/04/08/india s-solution-to-drug-costs-ignore-patents-and-control-pricesexceptfor-home-grown-drugs/#565732292cba (accessed on 20 August 2017).

  • A New York Times editorial came out in support of the Indian decision on Glivec, https://www.forbes.com/ sites/johnlamattina/2013/04/08/indias-solution-to-drug-costsignorepatents-and-control-prices-except-for-home-growndrugs/# 4b838d292cba, (accessed on 22 November 2017) by John La Mattina.

  • Mattina J L, Pharma& Healthcare, 2013, https://www.forbes.com/sites/johnlamattina/2013/04/08/indias-solution-todrugcosts-ignore-patents-and-control-prices-except-for-homegrowndrugs/#565732292cba (accessed on 20 August 2017), https://in.zapmetasearch.com/ ws?q=sustainable%20developement &de=c&asid=zm_in_ba_2_cg1_07.


Abstract Views: 143

PDF Views: 101




  • International Legal Obligation of the State with reference to Intellectual Property Rights (Patents) vis-a- vis Right to Health:The Indian Case Study

Abstract Views: 143  |  PDF Views: 101

Authors

Vikas H. Gandhi
Gujarat National Law University, Attalika Avenue, Knowledge Corridor, PDPU Road, Koba, Gandhinagar, Gujarat-382 426, India

Abstract


The problem exists is between the constitutional obligation of the state (India) under fundamental rights, ie. Human rights to health, on one hand and international legal and economical obligations under the trade agreements, ie. WTO, TRIPS etc., on other hand. Intellectual property rights of pharmaceuticals are governed by patent law. India being a signatory of the GATT1 is governed by TRIPS apart from having its own national Intellectual Property Law. Members are held responsible under the human rights treaties to protect, promote and fulfilled the basic and minimum requirements of an individual in the state. While on the other side, the trade agreements and treaties does not provide sufficient space to protect those human rights. If the state has signed the trade related agreements they are required to protect the interest of the seller and it would be challenging for the signatory state to maintain balance between the interest of a seller and protection of right health.

This article explores the existing constitutional, legal and international provisions pertaining to right to health and patent laws in India. Theis article analyses judicial decisions passed by the Supreme Court of India on right to health, on TRIPS provisions and its implementations. The article has underlined existing situation and its interplay between human rights and pharma-patents. The article endorse on right to health as human rights and constitutional rights vis a vis patent’s right under the trade agreements in India. The article explored the practice of pharmaceutical industry and its conflict with idea of right to health by analysis of landmark judgment Novartis Ag. v Union of India & Others, decided by the Supreme Court of India on 1 April 2013.The article further deliberates on access to patented medicines under the TRIPS.


Keywords


TRIPS, WHO, WIPO, WTO, Doha Declaration, PIL, Sustainable Development Goals.

References